Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

One of those people is Jason Amason, a 55-year-old Marine veteran. He has lived at the encampment located within White Slough on-and-off for 11 years – back when the land was only covered in ...

Parents need to know that Alvin and the Chipmunks: The Squeakuel is low-key, amusing entertainment for both parents and kids, with a mix of verbal and slapstick humor and only a few crude jokes. With ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

If anyone decides to create a professional Pop-A-Shot league, Eli Manning might look to end his retirement. The New York Giants legend has bragging rights over Caitlin Clark after defeating the ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1. ...

March 6 (Reuters) - Telehealth firms Teladoc (TDOC.N), opens new tab and LifeMD (LFMD.O), opens new tab said on Thursday they had signed an agreement to offer Eli Lilly's (LLY.N), opens new tab ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.